Professor Nebojsa Radovanovic
Emergency Center, Clinical Center of Serbia, University of Belgrade, Belgrade (Serbia)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Adding clinical markers of more severe form of intermediate-high risk pulmonary embolism improves risk stratification and possibly identifies candidates for fibrinolytic therapy
Event: ESC Acute CardioVascular Care 2022
Topic: Clinical
Session: Cardiac arrest, rhythm and other
Propensity score adjusted analysis of the association of thrombolytic therapy and 30-days outcome in patients with intermediate risk pulmonary embolism
Event: Acute Cardiovascular Care 2016
Topic: Thrombosis / embolism
Session: DVT and pulmonary embolism
ESC 365 is supported by
